Zts stock price surged after the company reported

ZTS stock price surged after the company reported higher-than-expected sales in livestock segment, driven by recovering global meat production. Growing its sales by 8% annually since 2013 -- compared to the broader animal healthcare industry's growth of 5% -- I'm confident in Zoetis' ability to innovate and succeed over the long haul. As the company navigates through this temporary, shorter-term rough patch, Zoetis remains one of my favorite buys, trading at a decade-low price-to-earnings (P/E) ratio of 25. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. With ZTS stock price trending positively, institutional buying volumes have increased, particularly from funds focused on biotech and veterinary pharma exposure. This volume pattern suggests confidence in medium-term price appreciation.